References

• Swedo SE. Trichotillomania. Hollander E (Ed). Obsessive-Compulsive Related Disorders. Washington DC: American Psychiatric Press; 1993; p. 93–111.
   Google Scholar
• Sadock VA, Sadock BJ (editors). Impulse-control disorders not elsewhere classified. Synopsis of Psychiatry. 9th edition. Philadelphia: Lippincot Williams & Wilkins; 2003; p. 790–2.
   Google Scholar
• American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, fourth ed. Washington. DC: American Psychiatric Association, 1994.
   Google Scholar
• Swedo SE, Leonard HL. Trichotillomania. An obsessive compulsive spectrum disorder? Psychiatr Clin North Am 1992; 15(4):777–90.
   PubMed Web of Science ®Google Scholar
• Zaimoğlu S. Dürtü Kontrol Bozuklukları. Çuhadaroğlu F, Coşkun A, Pehlivantürk B, İşeri E, Türkbay T, Miral S, Uslu R, Mukaddes NM, Ünal F, eds. Basic Book of Child and Adolescent Psychiatry. 1st edition. Hekimler Yayın Birliği; 2008; s. 540–53.
   Google Scholar
• Wright HH, Holmes GR. Trichotillomania (hair pulling) in toddlers. Psychol Rep 2003;92(1):228–30. [CrossRef]
   Web of Science ®Google Scholar
• Cohen LJ, Stein DJ, Simeon D, Spadaccini E, Rosen J, Aronowitz B, et al. Clinical profile, comorbidity, and treatment history in 123 hair pullers: A survey study. J Clin Psychiatry 1995;56(7):319–26.
   PubMed Web of Science ®Google Scholar
• Stanley MA, Breckenridge JK, Swann AC, Freeman EB, Reich L. Fluvoxamine treatment of trichotillomania. J Clin Psychopharmacol 1997;17(4):278–83. [CrossRef]
   Web of Science ®Google Scholar
• Konkan R, Şenormancı Ö, Sungur MZ. Diagnosis, pharmacotherapy and cognitive behavioral therapy of trichotillomania. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 2011;21(3):265–74. [CrossRef]
   Web of Science ®Google Scholar
• Potenza MN, Wasylink S, Epperson CN, McDougle CJ. Olanzapine augmentation of fluoxetine in the treatment of trichotillomania. Am J Psychiatry 1998;155(9):1299–1300.
   Web of Science ®Google Scholar
• Van Ameringen M, Mancini C, Oakman JM, Farvolden P. The potential role of haloperidol in the treatment of trichotillomania. J Affect Disord 1999;56(2–3):219–26. [CrossRef]
   Web of Science ®Google Scholar
• Sharma V, Corpse C. Lithium treatment of trichotillomania with comorbid bipolar II disorder. Arch Womens Ment Health 2008;11(4):305–6. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Adewuya EC, Zinser W, Thomas C. Trichotillomania: a case of response to Valproic Acid. J Child Adolesc Psychopharmacol 2008;18(5):533–6. [CrossRef]
   Web of Science ®Google Scholar
• Lochner C, Seedat S, Niehaus DJH, Stein DJ. Topirmate in the treatment of trichotillomania: an open-label pilot study. Int Clin Psychopharmacol 2006;21(5):255–9. [CrossRef]
   Web of Science ®Google Scholar
• De Sousa A. An open-label pilot study of naltrexone in childhoodonset trichotillomania. J Child Adolesc Psychopharmacol 2008;18(1):30–3. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Grant JE, Odlaug BL, Kim SW. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania. Arch Gen Psychiatry 2009;66(7):756–63. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Keuthen NJ, Rothbaum BO, Falkenstein MJ, Meunier S, Timpano KR, Jenike MA, et al. DBT-enhanced habit reversal treatment for trichotillomania: 3-and 6-month follow-up results. Depress Anxiety 2011;28(4):310–3. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Hautmann G, Hercogova J, Lotti T. Trichotillomania. J Am Acad Dermatol 2002;46(6):807–21. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Stewart RS, Netjek VA. An open-label, flexible-dose study of olanzapine in the treatment of trichotillomania. J Clin Psychiatry 2003;64(1):49–52. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Jefferys D, Burrows G. Reversal of trichotillomania with aripiprazole. Depress Anxiety 2008;25(6):E37-40. [CrossRef]
   Google Scholar
• Stein DJ, Bouwer C, Maud CM. Use of the selective serotonin reuptake inhibitor citalopram in treatment of trichotillomania. Eur Arch Psychiatry Clin Neurosci 1997;247(4):234–6. [CrossRef]
   Web of Science ®Google Scholar
• Gadde KM, Ryan Wagner H 2nd, Connor KM, Foust MS. Escitalopram treatment of trichotillomania. Int Clin Psychopharmacol 2007;22(1):39–42.
   Web of Science ®Google Scholar
• Christenson GA, Mackenzie TB, Mitchell JE, Callies AL. A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania. Am J Psychiatry 1991;148(11):1566–71.
   Web of Science ®Google Scholar
• Streichenwein SM, Thornby JI. A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania. Am J Psychiatry 1995;152(8):1192–6.
   Web of Science ®Google Scholar
• Dougherty DD, Loh R, Jenike MA, Keuthen NJ. Single modality versus dual modality treatment for trichotillomania: sertraline, behavioral therapy, or both? J Clin Psychiatry 2006;67(7):1086–92. [CrossRef]
   Web of Science ®Google Scholar
• White MP, Koran LM. Open-label trial of aripiprazole in the treatment of trichotillomania. J Clin Psychopharmacol 2011;31(4):503–6. [CrossRef]
   Web of Science ®Google Scholar
• Virit O, Selek S, Savas HA, Kokaçya H. Improvement of restless legs syndrome and trichotillomania with aripiprazole. J Clin Pharm Ther 2009;34(6):723–5. [CrossRef]
   Web of Science ®Google Scholar
• Ak M, Gulsun M. Aripiprazole in the Treatment of Trichotillomania: A Case Report. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 2010;20(2):176–8.
   Web of Science ®Google Scholar
• Stahl SM. Stahl's Essential Psychopharmacology, Neuroscientific and Practical Applications. 3rd edition. Uzbay T, trans. editor. 3. Baskı. Uzbay T, çev. editörü. İstanbul: İstanbul Tıp Kitapevi; 2012.
   Google Scholar